European Case Law Identifier: | ECLI:EP:BA:2006:T041102.20061107 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 07 November 2006 | ||||||||
Case number: | T 0411/02 | ||||||||
Application number: | 92914009.3 | ||||||||
IPC class: | C12N 15/62 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | CTL4A Receptor, fusion proteins containing it and uses thereof | ||||||||
Applicant name: | Bristol-Myers Squibb Company | ||||||||
Opponent name: | Genetics Institute | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Admissibility of the appeals (yes) Admission into the proceedings of documents (yes) Admission into the proceedings of requests (yes) Main request - added matter (yes) Auxiliary request 1 - extention of scope of protection (yes) Auxiliary request 2b - added matter, extention of scope of protection (no), clarity, sufficiency, novelty, inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020411eu1.html
Date retrieved: 17 May 2021